A new trading day began on Friday, with Agios Pharmaceuticals Inc (NASDAQ: AGIO) stock price up 5.49% from the previous day of trading, before settling in for the closing price of $25.31. AGIO’s price has ranged from $23.42 to $62.58 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 4.89%. Meanwhile, its annual earnings per share averaged -164.05%. With a float of $55.16 million, this company’s outstanding shares have now reached $57.16 million.
Let’s determine the extent of company efficiency that accounts for 488 employees. In terms of profitability, gross margin is 80.53%, operating margin of -1166.47%, and the pretax margin is 1967.15%.
Agios Pharmaceuticals Inc (AGIO) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Agios Pharmaceuticals Inc is 3.71%, while institutional ownership is 106.74%. The most recent insider transaction that took place on Apr 10 ’25, was worth 194,172. In this transaction Director of this company sold 7,497 shares at a rate of $25.90, taking the stock ownership to the 149,220 shares. Before that another transaction happened on Apr 08 ’25, when Company’s Director proposed sale 7,497 for $25.90, making the entire transaction worth $194,172.
Agios Pharmaceuticals Inc (AGIO) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.85 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -164.05% per share during the next fiscal year.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Trading Performance Indicators
Here are Agios Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.56. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 41.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 11.40, a number that is poised to hit -1.78 in the next quarter and is forecasted to reach -6.28 in one year’s time.
Technical Analysis of Agios Pharmaceuticals Inc (AGIO)
Looking closely at Agios Pharmaceuticals Inc (NASDAQ: AGIO), its last 5-days average volume was 0.89 million, which is a jump from its year-to-date volume of 0.75 million. As of the previous 9 days, the stock’s Stochastic %D was 41.30%. Additionally, its Average True Range was 1.90.
During the past 100 days, Agios Pharmaceuticals Inc’s (AGIO) raw stochastic average was set at 8.40%, which indicates a significant decrease from 37.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.16% in the past 14 days, which was higher than the 65.27% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $31.75, while its 200-day Moving Average is $41.36. However, in the short run, Agios Pharmaceuticals Inc’s stock first resistance to watch stands at $27.41. Second resistance stands at $28.13. The third major resistance level sits at $29.33. If the price goes on to break the first support level at $25.49, it is likely to go to the next support level at $24.29. Should the price break the second support level, the third support level stands at $23.57.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Key Stats
With a market capitalization of 1.53 billion, the company has a total of 57,296K Shares Outstanding. Currently, annual sales are 36,500 K while annual income is 673,730 K. The company’s previous quarter sales were 10,730 K while its latest quarter income was -96,520 K.
